Harmony Biosciences Holdings, Inc.
HRMY
$31.43
$0.491.58%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 19.44% | 8.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 19.44% | 8.53% | |||
| Cost of Revenue | 56.34% | 19.25% | |||
| Gross Profit | 10.76% | 6.28% | |||
| SG&A Expenses | -7.25% | 3.30% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.22% | 18.54% | |||
| Operating Income | 35.92% | -14.34% | |||
| Income Before Tax | 35.97% | -13.19% | |||
| Income Tax Expenses | 68.59% | -15.12% | |||
| Earnings from Continuing Operations | 27.88% | -12.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 27.88% | -12.70% | |||
| EBIT | 35.92% | -14.34% | |||
| EBITDA | 31.96% | -12.97% | |||
| EPS Basic | 27.70% | -12.94% | |||
| Normalized Basic EPS | 35.77% | -13.44% | |||
| EPS Diluted | 27.94% | -12.82% | |||
| Normalized Diluted EPS | 35.29% | -13.04% | |||
| Average Basic Shares Outstanding | 0.14% | 0.28% | |||
| Average Diluted Shares Outstanding | 0.50% | -0.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||